Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

Tiago F. Outeiro, Eirene Kontopoulos, Stephen M. Altmann, Irina Kufareva, Katherine E. Strathearn, Allison Amore, Catherine B. Volk, Michele M. Maxwell, Jean‐Christophe Rochet, Pamela J. McLean,

Science · 2007 · 1.1K citations · 22 references

DOIFull text

Open access

Concepts

Abstract

The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging. We identified a potent inhibitor of sirtuin 2 (SIRT2) and found that inhibition of SIRT2 rescued alpha-synuclein toxicity and modified inclusion morphology in a cellular model of Parkinson's disease. Genetic inhibition of SIRT2 via small interfering RNA similarly rescued alpha-synuclein toxicity. Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease. The results suggest a link between neurodegeneration and aging.

References

22